eMBR Genomics and Axio BioPharma Collaborate to Launch MKLP1 Pro™ Antibodies for Enhanced Cancer Research#USA#eMBR_Genomics#Axio_BioPharma#MKLP1_Pro#Madison,_Wisconsin
eMBR Genomics and Axio BioPharma Collaborate to Launch MKLP1 Pro™ Antibodies for Enhanced Cancer Research
eMBR Genomics partners with Axio BioPharma to commercialize MKLP1 Pro™ antibodies that advance cancer detection and cellular research globally.
third-news.com
January 6, 2025 at 12:13 PM
eMBR Genomics and Axio BioPharma Collaborate to Launch MKLP1 Pro™ Antibodies for Enhanced Cancer Research#USA#eMBR_Genomics#Axio_BioPharma#MKLP1_Pro#Madison,_Wisconsin